XML 39 R29.htm IDEA: XBRL DOCUMENT v3.22.1
Stock-Based Compensation (Tables)
3 Months Ended
Apr. 30, 2022
Share-based Payment Arrangement [Abstract]  
Summary of Stock Option Activity Under Equity Incentive Plans and Related Information

The following table summarizes the stock option activity under the equity incentive plans and related information:

 

 

 

Shares Subject to Options Outstanding

 

 

Weighted-
Average

 

 

 

 

 

 

 

 

 

Weighted-

 

 

Remaining

 

 

 

 

 

 

 

 

 

Average Exercise

 

 

Contractual Life

 

 

Aggregate

 

 

 

Shares

 

 

Price

 

 

(Years)

 

 

Intrinsic Value

 

 

 

 

 

 

 

 

 

 

 

 

(in thousands)

 

Balance as of January 31, 2022

 

 

5,726,893

 

 

$

11.74

 

 

 

3.04

 

 

$

82,481

 

Options granted

 

 

 

 

 

 

 

 

 

 

 

 

Options exercised

 

 

(2,056,625

)

 

 

2.99

 

 

 

 

 

 

 

Options forfeited/cancelled

 

 

(650,000

)

 

 

20.28

 

 

 

 

 

 

 

Balance as of April 30, 2022

 

 

3,020,268

 

 

$

15.85

 

 

 

4.04

 

 

$

44,607

 

Vested and expected to vest as of April 30, 2022

 

 

3,014,014

 

 

$

15.84

 

 

 

4.04

 

 

$

44,538

 

Exercisable as of April 30, 2022

 

 

2,894,679

 

 

$

15.69

 

 

 

3.92

 

 

$

43,212

 

 

Summary of Restricted Stock Unit Activity Under Equity Incentive Plans and Related Information

The following table summarizes the restricted stock unit activity under the equity incentive plans and related information:

 

 

 

Number of

 

 

Weighted-

 

 

 

Restricted

 

 

Average

 

 

 

Stock Units

 

 

Grant Date

 

 

 

Outstanding

 

 

Fair Value

 

Unvested balance - January 31, 2022

 

 

14,840,913

 

 

$

21.35

 

Granted

 

 

6,648,364

 

 

 

29.16

 

Vested

 

 

(2,376,125

)

 

 

22.75

 

Forfeited/cancelled

 

 

(718,642

)

 

 

21.34

 

Unvested balance - October 31, 2021

 

 

18,394,510

 

 

$

23.99

 

 

 

Summary of Components of Stock-Based Compensation Expense

The following table summarizes the components of stock-based compensation expense recognized in the condensed consolidated statements of operations (in thousands):

 

 

 

Three Months Ended

 

 

 

April 30,

 

 

 

2022

 

 

2021

 

Cost of revenue

 

$

4,355

 

 

$

5,340

 

Research and development

 

 

17,726

 

 

 

15,453

 

Sales and marketing

 

 

15,289

 

 

 

11,551

 

General and administrative

 

 

9,740

 

 

 

9,446

 

Total stock-based compensation

 

$

47,110

 

 

$

41,790